The Prevalence of Obesity and Metabolic Syndrome among Polish Women without Pre-Existing Cardiovascular Conditions and Diabetes: A Multicenter Study in Poland
Abstract
:1. Introduction
2. Materials and Methods
- (a)
- Being a woman;
- (b)
- Age ≥ 35 years;
- (c)
- No previously diagnosed cardiovascular conditions, diabetes or chronic kidney disease;
- (d)
- Informed, written consent to participate in the study;
- (e)
- Performance of laboratory tests within the past few weeks, which included a lipid panel (total cholesterol, HDL, LDL, non-HDL, triglycerides) and fasting serum glucose levels;
- (f)
- The completion of the HLPCQ (the Healthy Lifestyle and Personal Control Questionnaire).
- (1)
- Healthy dietary choices—questions 1, 3, 4, 5, 13, 14 and 16; maximum number of points—28.
- (2)
- Avoidance of harmful diets—questions 8, 9, 10 and 11; maximum number of points—16.
- (3)
- Daily routine—questions 2, 6, 7, 12, 15, 17, 19 and 22; maximum number of points—32.
- (4)
- Organized physical exercise—questions 20 and 23; maximum number of points—8.
- (5)
- Social and mental balance—questions 18, 21, 24, 25 and 26; maximum number of points—20 [22].
- (1)
- Established obesity (defined as BMI ≥ 30 kg/m2);
- (2)
- Established abdominal obesity, defined as a waist circumference ≥ 88 cm.
- (1)
- Serum fasting glucose ≥ 100 mg/dL;
- (2)
- Serum non-HDL ≥ 130 mg/dL;
- (3)
- Blood pressure ≥ 130 and/or 85 mmHg [18].
Statistical Analysis
3. Results
3.1. Description of the Study Group
3.2. Laboratory Test Results
3.3. Health Complications in Potentially Healthy Women
3.4. Lifestyle
3.5. Effect of Lifestyle on Health Problems
4. Discussion
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Clatici, V.G.; Voicu, C.; Voaides, C.; Roseanu, A.; Icriverzi, M.; Jurcoane, S. Diseases of Civilization—Cancer, Diabetes, Obesity and Acne—The Implication of Milk, IGF-1 and MTORC1. Maedica 2018, 13, 273–281. [Google Scholar] [PubMed]
- Huguet, N.; Larson, A.; Angier, H.; Marino, M.; Green, B.B.; Moreno, L.; Devoe, J.E. Rates of Undiagnosed Hypertension and Diagnosed Hypertension without Anti-Hypertensive Medication Following the Affordable Care Act. Am. J. Hypertens. 2021, 34, 989–998. [Google Scholar] [CrossRef] [PubMed]
- IDF. IDF Diabetes Atlas. 2021. IDF Off. Website 2021. pp. 1–4. Available online: https://diabetesatlas.org/ (accessed on 1 August 2024).
- Singer, M. Non-Communicable Diseases. In The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society; Wiley: Hoboken, NJ, USA, 2014; pp. 1686–1690. [Google Scholar]
- Gambert, S.R. The Burden of Chronic Disease. Clin. Geriatr. 2006, 14, 5. [Google Scholar]
- Aekplakorn, W. The Thai National Health Examination Survey. Available online: https://assets.adobe.com/public/339f7919-70a0-4d09-4a3a-41e4c74e3965 (accessed on 1 August 2024).
- Hypertension. Available online: https://www.who.int/news-room/fact-sheets/detail/hypertension (accessed on 1 August 2024).
- Uhernik, A.I.; Kralj, V.; Čukelj, P.; Brkić-Biloš, I.; Erceg, M.; Benjak, T.; Stevanović, R. Undiagnosed Hypertension in Croatia. Croat. Med. J. 2023, 64, 4–12. [Google Scholar] [CrossRef]
- Campbell, E.; Macey, E.; Shine, C.; Nafilyan, V.; Clark, N.C.; Pawelek, P.; Ward, I.; Hughes, A.; Raleigh, V.; Banerjee, A.; et al. Sociodemographic and Health-Related Differences in Undiagnosed Hypertension in the Health Survey for England 2015–2019: A Cross-Sectional Cohort Study. eClinicalMedicine 2023, 65, 102275. [Google Scholar] [CrossRef] [PubMed]
- Chau, K.; Girerd, N.; Zannad, F.; Rossignol, P.; Boivin, J.M. Health-Related Determinants of Undiagnosed Arterial Hypertension: A Population-Based Study. Fam. Pract. 2018, 36, 276–283. [Google Scholar] [CrossRef]
- Vaamonde, J.G.; Álvarez-Món, M.A. Obesity and Overweight. Medicine 2020, 13, 767–776. [Google Scholar] [CrossRef]
- Eurostat. Overweight and Obesity—BMI Statistics—Statistics Explained. Eurostat Stat. Explain. 2021, 2014, 1–9. [Google Scholar]
- Boutari, C.; Mantzoros, C.S. A 2022 Update on the Epidemiology of Obesity and a Call to Action: As Its Twin COVID-19 Pandemic Appears to Be Receding, the Obesity and Dysmetabolism Pandemic Continues to Rage On. Metabolism 2022, 133, 155217. [Google Scholar] [CrossRef]
- Stierman, B.; Afful, J.; Carroll, M.D.; Chen, T.C.; Davy, O.; Fink, S.; Fryar, C.D.; Gu, Q.; Hales, C.M.; Hughes, J.P.; et al. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. Natl. Health Stat. Rep. 2021, 2021, 1027–1050. [Google Scholar] [CrossRef]
- Profilaktyka i Leczenie Otyłości Przerosły System (Zapis Konferencji Prasowej)—Najwyższa Izba Kontroli. Available online: https://www.nik.gov.pl/aktualnosci/coraz-wiecej-osob-z-choroba-otylosciowa-coraz-dluzsze-kolejki.html (accessed on 1 August 2024).
- Chandrasekaran, P.; Weiskirchen, R. The Role of Obesity in Type 2 Diabetes Mellitus—An Overview. Int. J. Mol. Sci. 2024, 25, 1882. [Google Scholar] [CrossRef] [PubMed]
- Mathers, C. Global Burden of Disease. In International Encyclopedia of Public Health; Elsevier: Amsterdam, The Netherlands, 2016; pp. 256–267. ISBN 9780128037089. [Google Scholar]
- Dobrowolski, P.; Prejbisz, A.; Kuryłowicz, A.; Baska, A.; Burchardt, P.; Chlebus, K.; Dzida, G.; Jankowski, P.; Jaroszewicz, J.; Jaworski, P.; et al. Metabolic Syndrome—A New Definition and Management Guidelines. Arter. Hypertens. 2022, 26, 99–121. [Google Scholar] [CrossRef]
- Rajca, A.; Wojciechowska, A.; Śmigielski, W.; Drygas, W.; Piwońska, A.; Pająk, A.; Tykarski, A.; Kozakiewicz, K.; Kwaśniewska, M.; Zdrojewski, T. Increase in the Prevalence of Metabolic Syndrome in Poland: Comparison of the Results of the WOBASZ (2003–2005) and WOBASZ II (2013–2014) Studies. Pol. Arch. Intern. Med. 2021, 131, 520–526. [Google Scholar] [CrossRef]
- Al Thani, M.; Al Thani, A.A.; Al-Chetachi, W.; Al Malki, B.; Khalifa, S.A.H.; Bakri, A.H.; Hwalla, N.; Nasreddine, L.; Naja, F. A ‘High Risk’ Lifestyle Pattern Is Associated with Metabolic Syndrome among Qatari Women of Reproductive Age: A Cross-Sectional National Study. Int. J. Mol. Sci. 2016, 17, 698. [Google Scholar] [CrossRef] [PubMed]
- Nyberg, S.T.; Singh-Manoux, A.; Pentti, J.; Madsen, I.E.H.; Sabia, S.; Alfredsson, L.; Bjorner, J.B.; Borritz, M.; Burr, H.; Goldberg, M.; et al. Association of Healthy Lifestyle with Years Lived Without Major Chronic Diseases. JAMA Intern. Med. 2020, 180, 760–768. [Google Scholar] [CrossRef]
- Czapla, M.; Juárez-Vela, R.; Rozensztrauch, A.; Karniej, P.; Uchmanowicz, I.; Santolalla-Arnedo, I.; Baska, A. Psychometric Properties and Cultural Adaptation of the Polish Version of the Healthy Lifestyle and Personal Control Questionnaire (Hlpcq). Int. J. Environ. Res. Public Health 2021, 18, 9190. [Google Scholar] [CrossRef]
- Phelps, N.H.; Singleton, R.K.; Zhou, B.; Heap, R.A.; Mishra, A.; Bennett, J.E.; Paciorek, C.J.; Lhoste, V.P.; Carrillo-Larco, R.M.; Stevens, G.A.; et al. Worldwide Trends in Underweight and Obesity from 1990 to 2022: A Pooled Analysis of 3663 Population-Representative Studies with 222 Million Children, Adolescents, and Adults. Lancet 2024, 403, 1027–1050. [Google Scholar] [CrossRef]
- Escobar-Morreale, H.F.; Santacruz, E.; Luque-Ramírez, M.; Carretero, J.I.B. Prevalence of “obesity-Associated Gonadal Dysfunction” in Severely Obese Men and Women and Its Resolution after Bariatric Surgery: A Systematic Review and Meta-Analysis. Hum. Reprod. Update 2017, 23, 390–408. [Google Scholar] [CrossRef] [PubMed]
- Lewitt, M.; Dent, M.; Hall, K. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J. Clin. Med. 2014, 3, 1561–1574. [Google Scholar] [CrossRef]
- Censin, J.C.; Peters, S.A.E.; Bovijn, J.; Ferreira, T.; Pulit, S.L.; Mägi, R.; Mahajan, A.; Holmes, M.V.; Lindgren, C.M. Causal Relationships between Obesity and the Leading Causes of Death in Women and Men. PLoS Genet. 2019, 15, e1008405. [Google Scholar] [CrossRef]
- MedSci, K.K.F.; Schnecke, V.; Haase, C.L.; Harder-Lauridsen, N.M.; Rathor, N.; Sommer, K.; Morgen, C.S. Weight Change and Risk of Obesity-Related Complications: A Retrospective Population-Based Cohort Study of a UK Primary Care Database. Diabetes Obes. Metab. 2023, 25, 2669–2679. [Google Scholar] [CrossRef]
- Abohelwa, M.; Kopel, J.; Shurmur, S.; Ansari, M.M.; Awasthi, Y.; Awasthi, S. The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review. J. Vasc. Dis. 2023, 2, 122–164. [Google Scholar] [CrossRef]
- Shariq, O.A.; Mckenzie, T.J. Obesity-Related Hypertension: A Review of Pathophysiology, Management, and the Role of Metabolic Surgery. Gland Surg. 2020, 9, 80–93. [Google Scholar] [CrossRef] [PubMed]
- Nussbaumerova, B.; Rosolova, H. Obesity and Dyslipidemia. Curr. Atheroscler. Rep. 2023, 25, 947–955. [Google Scholar] [CrossRef]
- Sahadevan, P.; Kamal, V.K.; Sasidharan, A.; Bagepally, B.S.; Kumari, D.; Pal, A. Prevalence and Risk Factors Associated with Undiagnosed Diabetes in India: Insights from NFHS-5 National Survey. J. Glob. Health 2023, 13, 04135. [Google Scholar] [CrossRef]
- Basu, S.; James Thirunavukarasu, A.; Maheshwari, V.; Zode, M.; Hassan, R. Burden, Determinants and Treatment Status of Metabolic Syndrome among Older Adults in India: A Nationally Representative, Community-Based Cross-Sectional Survey. BMJ Public Health 2023, 1, e000389. [Google Scholar] [CrossRef]
- Mastwyk, S.; Taylor, N.F.; Lowe, A.; Dalton, C.; Peiris, C.L. Metabolic Syndrome Is Prevalent and Undiagnosed in Clients Attending Private Practice Physiotherapy: A Cross-Sectional Study. Physiotherapy 2024, 124, 116–125. [Google Scholar] [CrossRef]
- Chomiuk, T.; Niezgoda, N.; Mamcarz, A.; Śliż, D. Physical Activity in Metabolic Syndrome. Front. Physiol. 2024, 15, 1365761. [Google Scholar] [CrossRef]
- Niemiro, G.M.; Rewane, A.; Algotar, A.M. Exercise and Fitness Effect on Obesity. Available online: https://pubmed.ncbi.nlm.nih.gov/30969715/ (accessed on 4 August 2024).
- Andualem, A.; Gelaye, H.; Damtie, Y. Adherence to Lifestyle Modifications and Associated Factors among Adult Hypertensive Patients Attending Chronic Follow-up Units of Dessie Referral Hospital, North East Ethiopia, 2020. Integr. Blood Press. Control 2020, 13, 45–156. [Google Scholar] [CrossRef]
Variable | The Whole Group (N = 672) | Without Obesity (N = 533) | Obesity (N = 139) | p | |
---|---|---|---|---|---|
Age M ± SD | 47.9 ± 9.3 | 47.1 ± 9.1 | 51.2 ± 9.3 | <0.001 † | |
Weight [kg] M ± SD | 70.4 ± 15.3 | 64.7 ± 8.8 | 92.3 ± 15.1 | <0.001 † | |
Height [cm] M ± SD | 164.1 ± 6.4 | 164.3 ± 6.4 | 163.2 ± 6.5 | 0.091 † | |
Waist circumference [cm] M ± SD | 84.5 ± 13.1 | 79.9 ± 9.1 | 102.2 ± 10.8 | <0.001 † | |
Type of profession | White-collar worker | 322 (47.9) | 280 (87.0) | 42 (13.0) | <0.001 |
Manual worker | 145 (21.6) | 114 (78.6) | 31 (21.4) | ||
Farmer | 49 (7.3) | 34 (69.4) | 15 (30.6) | ||
Pensioner | 80 (11.9) | 45 (65.0) | 28 (35.0) | ||
Other | 76 (11.3) | 53 (69.7) | 23 (30.3) | ||
Education | Basic vocational | 145 (21.5) | 98 (67.5) | 47 (23.5) | 0.004 |
Secondary | 197 (29.4) | 151 (76.7) | 46 (23.3) | ||
Higher | 318 (47.3) | 275 (86.4) | 43 (13.6) | ||
Other | 12 (1.2) | 9 (75.0) | 3 (25.0) | ||
Place of residence | Village | 206 (30.7) | 152 (73.8) | 54 (26.2) | 0.002 |
City of up to 50,000 inhabitants | 169 (25.1) | 127 (75.2) | 42 (24.8) | ||
City of over 50,000 inhabitants | 297 (44.2) | 254 (85.5) | 43 (14.5) | ||
Heart attack and/or stroke in a father under 55? | 57 (8.5) | 44 (77.2) | 13 (22.8) | 0.679 ‡ | |
Heart attack and/or stroke in a mother under 65? | 29 (4.3) | 23 (79.3) | 6 (20.7) | 0.994 ‡ | |
Smoking | Smokes cigarettes | 147 (21.9) | 110 (74.8) | 37 (25.2) | 0.408 ‡ |
Smoked in the past | 94 (14.0) | 77 (81.9) | 17 (18.1) | ||
Passively smokes | 15 (2.2) | 11 (73.3) | 4 (26.7) | ||
Does not smoke | 416 (61.9) | 335 (80.5) | 81 (19.5) | ||
Moderate physical activity | I don’t do that kind of activity | 271 (40.3) | 206 (76.0) | 65 (24.0) | 0.295 ‡ |
1–2 times a week | 146 (21.7) | 122 (83.6) | 24 (16.4) | ||
3–4 times a week | 123 (18.3) | 100 (81.3) | 23 (18.7) | ||
>4 times a week | 132 (19.6) | 105 (79.6) | 27 (20.5) | ||
Average time of moderate physical activity [min/week] | 162.9 ± 374.7 | 154.3 ± 338.3 | 196.1 ± 489.9 | 0.411 † | |
Intense physical activity | I don’t do that kind of activity | 546 (81.3) | 430 (78.8) | 116 (21.2) | 0.614 ‡ |
1–2 times a week | 57 (8.5) | 48 (84.2) | 9 (15.8) | ||
3–4 times a week | 42 (6.2) | 35 (83.3) | 7 (16.7) | ||
>4 times a week | 27 (4.0) | 20 (74.1) | 7 (25.9) | ||
Average time of intense physical activity [min/week] | 26.8 ± 96.2 | 28.7 ± 102.7 | 19.8 ± 64.9 | 0.418 † |
Variable | The Whole Group (N = 672) | Without Obesity (N = 533) | Obesity (N = 139) | p |
---|---|---|---|---|
SBP [mmHg] M ± SD | 126.8 ± 16.9 | 124.3 ± 16.2 | 136.5 ± 16.4 | <0.001 |
DBP [mmHg] M ± SD | 80.4 ± 9.8 | 79.1 ± 9.6 | 84.9 ± 9.2 | <0.001 |
Heart action [beats per minute] M ± SD | 75.1 ± 10.7 | 74.9 ± 10.5 | 76.0 ± 11.5 | 0.403 |
Total cholesterol [mg/dL] M ± SD | 205.0 ± 40.8 | 203.5 ± 41.2 | 210.8 ± 38.7 | 0.019 |
LDL [mg/dL] M ± SD | 122.7 ± 38.0 | 120.8 ± 37.8 | 129.7 ± 37.9 | 0.004 |
HDL [mg/dL] M ± SD | 62.9 ± 15.7 | 64.8 ± 15.4 | 55.4 ± 14.4 | <0.001 |
Non-HDL [mg/dL] M ± SD | 142.5 ± 41.6 | 138.9 ± 41.4 | 156.2 ± 39.5 | <0.001 |
Triglycerides [mg/dL] M ± SD | 108.0 ± 60.3 | 99.7 ± 55.3 | 139.7 ± 67.9 | <0.001 |
Glucose [mg/dL] M ± SD | 92.1 ± 16.0 | 90.3 ± 10.4 | 99.2 ± 27.7 | <0.001 |
Variable | The Whole Group (N = 672) | Without Obesity (N = 533) | Obesity (N = 139) | p |
---|---|---|---|---|
Serum fasting glucose ≥ 100 mg/dL | 113 (16.8) | 66 (12.4) | 47 (33.8) | <0.001 |
Serum non-HDL ≥ 130 mg/dL | 388 (57.7) | 285 (53.5) | 103 (74.1) | <0.001 |
Blood pressure ≥ 130 and/or 85 mmHg | 312 (46.4) | 211 (39.6) | 101 (72.7) | <0.001 |
BMI ≥ 30 | 139 (20.6) | 0 (0.0 | 139 (100.0) | <0.001 |
Abdominal obesity (waist circumference ≥ 88 cm) | 247 (36.8) | 115 (21.6) | 132 (53.4) | <0.001 |
Metabolic syndrome | 150 (22.3) | 60 (40.0) | 90 (60.0) | <0.001 |
HLPCQ | The Whole Group (N = 672) | Without Obesity (N = 533) | Obesity (N = 139) | p |
---|---|---|---|---|
Healthy dietary choices | 18.0 ± 3.6 | 18.1 ± 3.6 | 17.6 ± 3.5 | 0.146 |
Dietary harm avoidance | 11.3 ± 2.8 | 11.4 ± 2.8 | 10.9 ± 3.1 | 0.096 |
Daily routine | 20.9 ± 5.4 | 21.2 ± 5.4 | 19.8 ± 5.5 | 0.004 |
Organized physical exercise | 4.3 ± 1.8 | 4.3 ± 1.8 | 3.9 ± 1.7 | 0.005 |
Social and mental balance | 13.1 ± 3.0 | 13.2 ± 3.0 | 12.9 ± 3.0 | 0.190 |
Final result | 67.6 ± 12.4 | 68.3 ± 12.4 | 65.0 ± 12.2 | 0.007 |
Variable | HLPCQ | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthy Dietary Choices | Dietary Harm Avoidance | Daily Routine | Organized Physical Exercise | Social and Mental Balance | Final Result | |||||||
OR [95 Cl] | p | OR [95 Cl] | p | OR [95 Cl] | p | OR [95 Cl] | p | OR [95 Cl] | p | OR [95 Cl] | p | |
Serum fasting glucose ≥ 100 mg/dL | 0.98 [0.91, 1.06] | 0.534 | 1.02 [0.94, 1.11] | 0.662 | 0.97 [0.93, 1.02] | 0.273 | 0.87 [0.76, 1.01] | 0.073 | 0.98 [0.96, 0.99] | 0.048 | 1.00 [0.98, 1.02] | 0.663 |
Serum non-HDL ≥ 130 mg/dL | 0.95 [0.89, 1.01] | 0.118 | 1.02 [0.95, 1.09] | 0.622 | 0.97 [0.93, 1.01] | 0.124 | 0.95 [0.86, 1.06] | 0.378 | 1.01 [0.95, 1.08] | 0.633 | 0.97 [0.95, 0.99] | 0.014 |
Blood pressure ≥ 130 and/or 85 mmHg | 0.98 [0.92, 1.04] | 0.454 | 0.99 [0.93, 1.06] | 0.775 | 1.01 [0.98, 1.05 | 0.456 | 0.94 [0.84, 1.04] | 0.231 | 1.01 [0.95, 1.08] | 0.718 | 0.95 [0.92, 1.05] | 0.213 |
BMI ≥ 30 | 1.03 [0.96, 1.12] | 0.321 | 0.94 [0.87, 1.01] | 0.113 | 0.94 [0.91, 0.99] | 0.017 | 0.88 [0.77, 0.98] | 0.045 | 1.03 [0.95, 1.11] | 0.407 | 0.97 [0.96, 0.99] | 0.007 |
Abdominal obesity (waist circumference ≥ 88 cm) | 1.01 [0.95, 1.07] | 0.741 | 0.93 [0.87, 0.99] | 0.032 | 0.97 [0.93, 1.00] | 0.064 | 0.88 [0.79, 0.99] | 0.034 | 1.05 [0.98, 1.13] | 0.112 | 0.98 [0.96, 0.99] | 0.004 |
Metabolic syndrome | 0.97 [0.89, 1.03] | 0.343 | 0.99 [0.92, 1.07] | 0.822 | 0.97 [0.93, 1.02] | 0.216 | 0.88 [0.77, 0.98] | 0.048 | 1.07 [0.99, 1.17] | 0.073 | 0.98 [0.97, 1.00] | 0.171 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Babicki, M. The Prevalence of Obesity and Metabolic Syndrome among Polish Women without Pre-Existing Cardiovascular Conditions and Diabetes: A Multicenter Study in Poland. J. Clin. Med. 2024, 13, 5014. https://doi.org/10.3390/jcm13175014
Babicki M. The Prevalence of Obesity and Metabolic Syndrome among Polish Women without Pre-Existing Cardiovascular Conditions and Diabetes: A Multicenter Study in Poland. Journal of Clinical Medicine. 2024; 13(17):5014. https://doi.org/10.3390/jcm13175014
Chicago/Turabian StyleBabicki, Mateusz. 2024. "The Prevalence of Obesity and Metabolic Syndrome among Polish Women without Pre-Existing Cardiovascular Conditions and Diabetes: A Multicenter Study in Poland" Journal of Clinical Medicine 13, no. 17: 5014. https://doi.org/10.3390/jcm13175014
APA StyleBabicki, M. (2024). The Prevalence of Obesity and Metabolic Syndrome among Polish Women without Pre-Existing Cardiovascular Conditions and Diabetes: A Multicenter Study in Poland. Journal of Clinical Medicine, 13(17), 5014. https://doi.org/10.3390/jcm13175014